Contact
Please use this form to send email to PR contact of this press release:
Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH 2018
TO:
Please use this form to send email to PR contact of this press release:
Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH 2018
TO: